Detalhe da pesquisa
1.
Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1.
N Engl J Med
; 389(4): 309-321, 2023 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494485
2.
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER).
Clin Gastroenterol Hepatol
; 2023 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37743037
3.
Impact of Concomitant 5-Aminosalicylic Acid Therapy on Vedolizumab Efficacy and Safety in Inflammatory Bowel Disease: Post Hoc Analyses of Clinical Trial Data.
J Crohns Colitis
; 17(12): 1949-1961, 2023 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37492976
4.
Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn's Disease: Results from the Phase 2 HUBBLE Study.
J Crohns Colitis
; 16(8): 1243-1254, 2022 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301512
5.
Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease.
Clin Pharmacokinet
; 60(6): 811-818, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33544318
6.
Assessment of Vedolizumab Disease-Drug-Drug Interaction Potential in Patients With Inflammatory Bowel Diseases.
Clin Pharmacol Drug Dev
; 10(7): 734-747, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33331142